Clonal Deletion on Living-Relative Donor Kidney Transplantation
Status:
Unknown status
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The objective of this trial is to determine if clonal deletion before kidney transplantation
can effectively reduce the need for post transplant immunosuppression. The investigators will
adapt a DAWN (Drugs (immunosuppressants) Added When Needed) treatment protocol to assess the
effect of clonal deletion and closely monitor acute rejection, renal function, and graft
survival. 15 patients eligible for the study as described below will be enrolled.